Navigation Links
Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Date:1/25/2012

RESEARCH TRIANGLE PARK, N.C., Jan. 25, 2012 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that final data from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV), has been accepted for oral presentation at the BMT Tandem Meetings on February 1-5, 2012, in San Diego, California.  CMX001 is a broad spectrum, Lipid-Antiviral-Conjugate completing Phase 2 clinical development for the prevention of CMV in hematopoietic cell transplant (HCT) recipients.  In total, three abstracts related to CMX001 have been accepted for presentation at the 2012 BMT Tandem Meetings, the combined annual meetings of the Center for International Blood and Marrow Transplant Research (CIBMTR) and the American Society of Blood and Marrow Transplantation (ASBMT).

Francisco Marty, MD, Assistant Professor of Medicine at Brigham and Women's Hospital's Division of Infectious Disease and a lead investigator in Chimerix's CMX001 Phase 2 CMV study, will present the data during the "Best Abstracts Plenary Session" at 4:45 pm on Friday, February 3 in the Elizabeth Ballroom at the Manchester Grand Hyatt in San Diego.  The presentation, entitled "CMX001 for Prevention and Control of CMV Infection in CMV-Seropositive Allogeneic Stem Cell Transplant Recipients: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Trial of Safety, Tolerability and Antiviral Activity," will highlight safety and efficacy results from the Phase 2 trial in 230 hematopoietic cell transplant recipients.  

"Existing therapies for the prophylaxis and treatment of viral infections, including CMV, in the transplant recipient population are limited by their lack of broad spectrum efficacy and major side effects, notably nephrotoxicity and myelosuppression," said Wendy P. Painter, MD, MPH, Chimerix's Chief Medical Officer.  "The prevalence of the disease and the limita
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences
2. Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital Transaction" Award
3. Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting
4. Chimerix to Present at Infocasts 9th Annual Biodefense Vaccines & Therapeutics Conference
5. Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
6. Chimerix to Present at Cowen and Company 31st Annual Health Care Conference
7. Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerixs Lead Antiviral CMX001
8. Chimerix to Present at the Citi 2011 Global Health Care Conference
9. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Voalte, the ... global leader in purpose-built wireless communications, today announced ... Regional), a 104-bed acute-care facility in ... the Voalte One™ solution on Spectralink PIVOT™ purpose-built ... Spectralink named Voalte a member of its AIMS ...
(Date:7/28/2015)... 28, 2015 Egalet Corporation (Nasdaq: ... company focused on developing, manufacturing and marketing innovative ... underwritten public offering of 6,666,667 shares of its ... $11.25 per share. The gross proceeds to Egalet ... $75 million, before deducting the underwriting discounts and ...
(Date:7/28/2015)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... (AACC) 2015 Clinical Lab Expo today by introducing ... educational initiative that demonstrates how Roche is partnering ... laboratory. The new LabLeaders initiative ( ... the people within them through insight from industry ...
Breaking Medicine Technology:Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3Egalet Announces Pricing of Public Offering of Common Stock 2Egalet Announces Pricing of Public Offering of Common Stock 3Egalet Announces Pricing of Public Offering of Common Stock 4Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 2Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 3Roche introduces LabLeaders educational initiative to help redefine the value of the laboratory at AACC 2015 Clinical Lab Expo 4
... , TAI,AN, China, ... (Nasdaq: CBPO ) ("China Biologic," or,the "Company"), one of the ... received approval to list its,common stock on the NASDAQ Global Market. ... begin trading on the NASDAQ on,Wednesday, December 2, 2009, until which ...
... SAN DIEGO, Dec. 1 ADVENTRX Pharmaceuticals, Inc. (NYSE ... recently completed preclinical study has affirmed the bioequivalence and ... Poong Pharmaceuticals, ADVENTRX,s partner for ANX-514 in South Korea, ... , "Our independent confirmation of the bioequivalence and comparable ...
Cached Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3
(Date:7/28/2015)... Nashville, Tenn. (PRWEB) , ... July 28, 2015 ... ... has added the SmileCareClub Invisible Aligner System to its online product ... , By using a teledentistry model and cloud-based technology, SmileCareClub allows patients to ...
(Date:7/28/2015)... Wayne, PA (PRWEB) , ... July 28, 2015 ... ... that its Board of Directors has authorized the Company, from time to time ... with an aggregate value of up to $25 million. Repurchases will be made ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... services to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... evidence based. It provides physicians who are anticipating making a subspecialty referral ...
(Date:7/28/2015)... ... 2015 , ... Fertility specialist Dr. Lisa Hasty of Atlanta Center ... Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for ... in the metro area as one of the most respected doctors in Reproductive Endocrinology. ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published ... Fibromyalgia, Study Says " sheds light on a possible new treatment option for people ... months of regular HBOT sessions, at least five per week, patients experienced a significant ...
Breaking Medicine News(10 mins):Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 2Health News:Brookstone Now Offers SmileCareClub Teeth Straightening System 3Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3
... - Region,s Fastest Growing Private Company* Delivers Quality, ... in Patients, Needs -, GLENDALE, Calif., Nov. ... (2005 through 2007) earned it the status as ... the region,s top business media,Lakeside Systems, Inc. (Lakeside) ...
... Increases Fund Size for Venture Team by 30%, ... Ventures (, http://www.morgenthaler.com/ventures ), a leading venture ... today that it has exceeded its,fundraising goal and ... $400,million. This brings the firm,s total capital under ...
... PLC Systems Inc.,(Pink Sheets: PLCSF), a company ... today stated that, following the,delisting of its common ... Stock Exchange) on Monday, November 10, 2008, the ... its common stock listing to the,OTCBB. Until that ...
... articles that stress African-American health disparities, like higher ... black patients from being screened for cancer, according ... are more likely to be tested for cancer ... among African-American cancer patients. , While the medical ...
... International Conference on Wireless ... Identification in Milan, HATBORO, Pa., ... of enterprise mobility and advanced,wireless asset tracking solutions for the healthcare ... on the predictive value of identification technology at the ID,WORLD International ...
... Closed in 2008, According to New Report,from HealthLeaders-InterStudy, ... provider of managed care market intelligence, reports that ... better than health systems,in other parts of the ... to the new Southern New Jersey Market Overview, ...
Cached Medicine News:Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 2Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 3Health News:Lakeside Systems, Inc. Unifies Integrated Healthcare Delivery System under New Brand: Lakeside Community Healthcare 4Health News:Morgenthaler Closes Ninth Fund at $400 Million 2Health News:Morgenthaler Closes Ninth Fund at $400 Million 3Health News:Morgenthaler Closes Ninth Fund at $400 Million 4Health News:PLC Systems Updates Common Stock Listing Status 2Health News:Messages of hope work better in motivating black patients to seek early screening for cancer 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 2Health News:InfoLogix CEO to Address Hidden Value of ID Technology at International Conference 3Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 2Health News:Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions 3
...
Ascent Primary Knee System with cruciate retaining, posterior stabilized and constrained components...
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... system continues the "Consensus Concept" approach to ... diversified experience of a Scientific Advisory Board. ... that incorporates state-of-the-art features. Consensus Knee implants ... implant stability and allow near normal kinematics. ...
Medicine Products: